Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
GTI Energy

Related Posts

Top 5 Canadian Mining Stocks This Week: Carlton...

September 6, 2025

Trading Halt

February 3, 2025

Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth...

September 16, 2025

Deadly Illegal Gold Mine Collapse in Mali Kills...

February 18, 2025

McDermitt Project Fast-Tracked Under U.S. FAST-41 Initiative

April 22, 2025

Skyharbour Closes $2.1 Million Private Placement of Flow-Through...

December 6, 2025

Chris Marcus: Silver Supply Crunch Not Over, Price...

November 13, 2025

Metals & Mining Virtual Investor Conference: Presentations Now...

July 26, 2025

Massan Indicated Conversion Programme Continues to Deliver

February 20, 2026

GNG: Preferred Contractor – Laverton Processing Plant

February 17, 2026

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 2

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2026 daytradingreports.com | All Rights Reserved